Oncoinfluencers to Follow on Social Media: Dr. Paolo Tarantino

Our next oncoinfluencer is Dr. Paolo Tarantino.

Dr. Tarantino is active on both X/Twitter and LinkedIn, where he regularly shares comprehensive insights into oncology. His posts range from the latest research publications to in-depth discussions on patient care and advancements in breast oncology, with a particular focus on HER2 and antibody-drug conjugates (ADCs). Dr. Tarantino’s consistent and informative updates make him a valuable resource for anyone keen on staying abreast of breast oncology developments.

Stay updated with Dr. Tarantino’s latest research and insights by following him on social media:
X/Twitter:@PTarantinoMD
LinkedIn: Paolo Tarantino

About Paolo Tarantino

Dr. Paolo Tarantino, MD, is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan.

His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a  publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field.

While staying tuned for upcoming Oncoinfluencers, check out previous profiles on our website on influential voices in the oncology community.